211 related articles for article (PubMed ID: 31191040)
1. A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany.
Xue W; Lloyd A; Falla E; Roeder C; Papsch R; Bühler K
Int J Womens Health; 2019; 11():319-331. PubMed ID: 31191040
[No Abstract] [Full Text] [Related]
2. Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France.
Lehmann M; Arbo E; Pouly JL; Barrière P; Boland LA; Bean SG; Jenkins J
Eur J Obstet Gynecol Reprod Biol X; 2024 Jun; 22():100311. PubMed ID: 38741750
[TBL] [Abstract][Full Text] [Related]
3. A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility.
Gizzo S; Garcia-Velasco JA; Heiman F; Ripellino C; Bühler K
Int J Womens Health; 2016; 8():683-689. PubMed ID: 27994486
[TBL] [Abstract][Full Text] [Related]
4. Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers.
Schwarze JE; Venetis C; Iniesta S; Falla E; Lukyanov V; de Agustin Calvo E; D Hooghe T; Roeder C; Matorras R
Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt B):203-216. PubMed ID: 35227619
[TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy and Spain.
Gizzo S; Ferrando M; Lispi M; Ripellino C; Cataldo N; Bühler K
J Med Econ; 2018 Nov; 21(11):1096-1101. PubMed ID: 30113238
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study.
Patel NH; Patel NH; Patel MN; Bhadarka HK; Vyas KS
J Hum Reprod Sci; 2023; 16(2):148-155. PubMed ID: 37547084
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis comparing the originator follitropin alfa to its biosimilars in patients undergoing a medically assisted reproduction program from a French perspective.
Grynberg M; Murphy C; Doré C; Fresneau L; Paillet S; Petrica N; Frédérique M; Ravonimbola H
J Med Econ; 2018 Nov; ():1-15. PubMed ID: 30461330
[TBL] [Abstract][Full Text] [Related]
8. Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis.
Chua SJ; Mol BW; Longobardi S; Orvieto R; Venetis CA; Lispi M; Storr A; D'Hooghe T
Reprod Biol Endocrinol; 2021 Apr; 19(1):51. PubMed ID: 33794909
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis.
Li H; He W; Lin H; Du A; Zhang X; Yang H; Qu S
Risk Manag Healthc Policy; 2024; 17():1387-1394. PubMed ID: 38828103
[TBL] [Abstract][Full Text] [Related]
10. Overlapping biosimilar and originator follitropin alfa preparations: How much closer can they get?
de Mora F; Howles CM
Drug Discov Today; 2022 Aug; 27(8):2071-2075. PubMed ID: 35490965
[TBL] [Abstract][Full Text] [Related]
11. Biosimilars versus the originator of follitropin alfa: Randomized controlled trials are still the best way to evaluate their comparative effectiveness in assisted reproduction.
Venetis CA; Mol BW
Drug Discov Today; 2023 Feb; 28(2):103425. PubMed ID: 36332833
[TBL] [Abstract][Full Text] [Related]
12. A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose.
Barrière P; Hamamah S; Arbo E; Avril C; Salle B; Pouly JL; Jenkins J;
J Gynecol Obstet Hum Reprod; 2023 Jan; 52(1):102510. PubMed ID: 36403900
[TBL] [Abstract][Full Text] [Related]
13. Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
Fragoulakis V; Pescott CP; Smeenk JM; van Santbrink EJ; Oosterhuis GJ; Broekmans FJ; Maniadakis N
Appl Health Econ Health Policy; 2016 Dec; 14(6):719-727. PubMed ID: 27581117
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation Pattern and
Riccetti L; Sperduti S; Lazzaretti C; Klett D; De Pascali F; Paradiso E; Limoncella S; Potì F; Tagliavini S; Trenti T; Galano E; Palmese A; Satwekar A; Daolio J; Nicoli A; Villani MT; Aguzzoli L; Reiter E; Simoni M; Casarini L
Front Endocrinol (Lausanne); 2019; 10():503. PubMed ID: 31396162
[TBL] [Abstract][Full Text] [Related]
15. The pharmacoeconomic impact of follitropin alpha biosimilars in IVF therapy in Europe: a report of the literature.
Šprem Goldštajn M; Mikuš M; Ćorić M; Orešković S; Dumančić S; Noventa M; Buzzaccarini G; Andrisani A; Laganà AS
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):553-558. PubMed ID: 33784935
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of follitropin alpha biosimilars compared to their reference product: a Meta-analysis.
Budani MC; Fensore S; Di Marzio M; Tiboni GM
Gynecol Endocrinol; 2021 May; 37(5):406-414. PubMed ID: 32654532
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
18. In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f).
Mastrangeli R; Satwekar A; Cutillo F; Ciampolillo C; Palinsky W; Longobardi S
PLoS One; 2017; 12(9):e0184139. PubMed ID: 28880909
[TBL] [Abstract][Full Text] [Related]
19. Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap
Winstel R; Wieland J; Gertz B; Mueller A; Allgaier H
Drugs R D; 2017 Jun; 17(2):305-312. PubMed ID: 28386738
[TBL] [Abstract][Full Text] [Related]
20. Biosimilar FSH preparations- are they identical twins or just siblings?
Orvieto R; Seifer DB
Reprod Biol Endocrinol; 2016 Jun; 14(1):32. PubMed ID: 27301324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
